Dataset Information

Expanding the global map of protein post translational modifications with PTMScan enrichment and nDIA analysis on the Orbitrap Astral

ABSTRACT: The study describes the use of PTMScan enrichment and LC-MS/MS analysis using Orbitrap Astral for the deep coverage of different PTM peptides from cells and tissue.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human) Mus Musculus (mouse)

TISSUE(S): Liver

SUBMITTER: Mukesh Kumar

LAB HEAD: Mukesh Kumar

PROVIDER: PXD065579 | Pride | 2026-05-21

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	011626-HCT116-AcK-HS-1000ugInput-Lumos-DDA-BR1-01.pepXML	Pepxml
	011626-HCT116-AcK-HS-1000ugInput-Lumos-DDA-BR1-01_uncalibrated.mzML	Mzml
	011626-HCT116-AcK-HS-100ugInput-Lumos-DDA-BR1-01.pepXML	Pepxml
	011626-HCT116-AcK-HS-100ugInput-Lumos-DDA-BR1-01_uncalibrated.mzML	Mzml
	011626-HCT116-AcK-HS-3000ugInput-Lumos-DDA-BR1-01.pepXML	Pepxml

Items per page:

1 - 5 of 679

Publications

Expanding the Global Map of Protein Post-Translational Modifications With Immunoaffinity Enrichment and nDIA Analysis on the Orbitrap Astral Mass Spectrometer.

Kumar Mukesh M Possemato Anthony P AP Zee Barry M BM Subramanian Srikanth S Ren Jian Min JM Nelson Alissa J AJ Zhang Bin B Landry Sean D SD Silva Jeffrey C JC Larsen Brett B Hart Tonya Pekar TP Stokes Matthew P MP Beausoleil Sean A SA

Molecular & cellular proteomics : MCP 20260406 5

Post-translational modifications (PTMs) contribute greatly to the diversity of the human proteome by affecting protein structure, function, interactions, stability, localization, and more. The study of PTMs is essential to understand various cellular functions, disease mechanisms, and aid in the development of biomarkers and design of therapeutic targets. Owing to their diversity, dynamic nature, and low stoichiometry compared to unmodified proteome counterparts, the analysis of PTMs remains cha ...[more]

PMID: 41951141

Similar Datasets

Project description:We highlight the leap in performance made possible with new instrumentation in the Thermo Scientific Orbitrap Astral™ mass spectrometer. Integrated alongside a high-resolution accurate mass (HRAM) Orbitrap analyzer, the instrument introduces a fast-switching quadrupole mass filter congruent with downstream speeds of ion detection, a dual-pressure ion processor cell which fragments ions in the high-pressure cell before they are moved to the low-pressure cell for further accumulation and orthogonal extraction to the Astral analyzer, and a high dynamic range detector. Altogether, ions can be manipulated in five stages of the MS at once (Orbitrap, ion routing multipole, two ion processor stages, Astral analyzer), allowing for a high degree of parallelization which enables MS/MS scan speeds of 200 Hz while HRAM MS1 full scans are synchronously acquired in the Orbitrap analyzer. To provide such fast scan speeds, the Astral analyzer is capable of single-ion detection sensitivity like a linear ion trap, all while enabling resolving powers of 80,000 at m/z 524. Here, in triplicate 7-min microflow active LC gradients on the Orbitrap Astral MS, we report 7,852 protein groups from 94,267 peptides on average. When employing 15-, 30-, and 60-min active, nano-LC gradients, triplicate experiments yield an average of 9,831, 10,411, and 10,645 unique protein groups from 195,612, 234,406, and 245,754 unique peptides, respectively. These nanoflow methods delivered a median sequence coverage of 38%, 42.4% and 44.4% across identified proteins for each respective gradient length. Our 30-min method delivered approximately 347 proteins per minute. Finally, we applied our 30-min active gradient method to analyze a CRISPR-Cas9 knockout (KO) of the mitochondrial gene MGME1 in human HAP1 cells. There, we quantified an average of 10,353 proteins across three technical replicates and find 449 significantly up- or down-regulated proteins relative to wild-type (WT) HAP1 proteins. Proteins from the same sample quantified using a 61-min active gradient Orbitrap Ascend DIA method show strong fold-change correlations to and gene ontology (GO) term agreement with our results.Building upon the immense progress of the mass spectrometry and proteomics communities of the past ten years, here we report alongside other recent works, that the one-hour human proteome is now within reach.